Only 1 participant (in the prophylaxis-stopped group) had adverse events of grade 3 or 4 (anemia,neutropenia, and presumed septicemia) that were adjudicated to be potentially related to co-trimoxazole; these events were also judged to be definitely related to zidovudine.